Pharmacy Program Information
Notice regarding Omontys Recall
Note: 02/24/2013: FDA is alerting health care providers and patients of a voluntary nationwide recall of ALL lots of Omontys Injection by Affymax and Takeda Pharmaceuticals. The recall is due to reports of anaphylaxis, some fatal. Omontys is used to treat anemia in adult dialysis patients. Until further notice, health care providers should stop using Omontys and return the product to Takeda. For details, please visit the FDA page and the Takeda/Affymax News Release.
Notice: Humana CareSource Pharmacy and Therapeutics Committee Meeting
As we get ready to launch our new managed Medicaid program in Kentucky, Humana CareSource is holding a public forum for its Pharmacy and Therapeutics Committee meeting. The meeting will be held at the Embassy Suites in Louisville on Oct. 30, from 10 a.m. - noon. Click here for more information.
Announcement - 5010 D.O Information
Please be advised that the Department for Medicaid Services and the Magellan Medicaid Administration will be transitioning from NCPDP Version 5.1 to NCPDP Version D.0 in the Kentucky Medicaid Pharmacy Program on Jan. 1, 2012. Updates
Announcement - Updated information
Please click on the Pharmacy Maximum Allowable Cost Program Information for updated information.
 |
Pharmacy Resources |
 |
|
KY MCO Prefered Drug Lists (PDL) |
|
|